Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Bliss GVS Pharma has informed that it enclosed disclosure of Related Party Transactions on the basis on consolidated financial statements for the half year ended March 31, 2021.
The above information is a part of company’s filings submitted to BSE.